Stay updated on Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe displayed site revision changes from v3.7.2 to v3.8.0, with no visible change to the study record.SummaryDifference0.1%

- Check21 days agoChange DetectedA notice appears at the top of the page about NIH’s website transition, including a statement that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.5%

- Check27 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check34 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check55 days agoChange DetectedThe study record history shows a new revision label (v3.7.0) replacing the previous v3.6.6. This indicates a platform-level revision of the history interface rather than a content update.SummaryDifference0.1%

- Check76 days agoChange DetectedThe record history shows a platform revision updated to v3.6.6, replacing the previous v3.6.5. This change represents a minor system update rather than modifications to study data or page content.SummaryDifference0.1%

Stay in the know with updates to Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial page.